Related Experiment Video

Updated: Jul 6, 2026

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

Supersized kidneys: Lessons from the preclinical obese kidney

V D D'Agati1, G S Markowitz

  • 1Department of Pathology, Columbia University, New York, New York 10032, USA. vdd1@columbia.edu

Kidney International
|April 2, 2008
PubMed

Insights

Obesity is rising globally and significantly increases kidney failure risk. Early structural and functional kidney changes in obesity are now better understood through studies of bariatric surgery patients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Public Health

Background:

  • Rising global obesity rates present a significant public health challenge.
  • Obesity is a known risk factor for the development and progression of renal failure, independent of other comorbidities.
  • Understanding the renal effects of obesity is crucial for nephrologists to develop effective interventions.

Discussion:

  • Kidney biopsies and functional studies in morbidly obese patients undergoing bariatric surgery offer insights into early renal changes.
  • These studies help elucidate the earliest structural and functional responses of the kidney to obesity.
  • Investigating these early changes is key to understanding obesity's impact on kidney health.

Key Insights:

  • Obesity induces specific structural and functional alterations in the kidneys.
  • Early detection of obesity-related kidney changes is possible even in the absence of overt renal disease.
  • Bariatric surgery patients provide a unique cohort for studying obesity's impact on renal physiology.

Outlook:

  • Further research is needed to fully characterize the long-term renal consequences of obesity.
  • Developing targeted therapies to mitigate obesity-induced kidney damage is a priority.
  • Enhanced understanding of obesity's renal effects will improve patient outcomes and inform public health strategies.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Kidney Procurement in a Preclinical Large Animal Model05:36

Kidney Procurement in a Preclinical Large Animal Model

Published on: May 2, 2025

Related Concept Videos

External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Kidney Structure01:45

Kidney Structure

The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...